A2DMQY Cronos Group Inc

Cronos Group Inc. to Hold 2023 First Quarter Earnings Conference Call on May 9, 2023

Cronos Group Inc. to Hold 2023 First Quarter Earnings Conference Call on May 9, 2023

TORONTO, April 25, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 first quarter earnings conference call on Tuesday, May 9, 2023 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

To attend the conference call or webcast, participants should register online at . To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company’s website.

About Cronos

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: .

Forward-looking Statements

This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 which has been filed on SEDAR and EDGAR and can be accessed at and /edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Cronos Contact

Shayne Laidlaw

Investor Relations

Tel: (416) 504-0004



EN
25/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE

Cronos Launches New All-in-One Vape, Spinach PUFFERZ™

Cronos Launches New All-in-One Vape, Spinach PUFFERZ™ Spinach PUFFERZ™ delivers a flavorful experience combining high-quality cannabis with a sleek tactile design, enhanced with liquid diamonds TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced today the launch of its newest all-in-one (AIO) vape, Spinach PUFFERZ™. The latest innovation under Cronos’ Spinach® brand brings together high-quality cannabis infused with liquid diamonds in a convenient all-in-one device. Crafted for modern ca...

 PRESS RELEASE

Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings C...

Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026 TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To...

 PRESS RELEASE

Cronos Group משיקה את מותג הפרימיום Lord Jones® בישראל ומקדמת אסטרטגי...

Cronos Group משיקה את מותג הפרימיום Lord Jones® בישראל ומקדמת אסטרטגיית מוצרים גלובלית חוצת גבולות טורונטו, Feb. 02, 2026 (GLOBE NEWSWIRE) --  חברת Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“קרונוס” או “החברה”), מהחברות הגלובליות המובילות בעולם הקנאבינואידים, הודיעה היום על השקת מותג הקנאביס הפרימיום Lord Jones® בישראל. ההשקה מהווה אבן דרך משמעותית באסטרטגיית המוצרים חוצת הגבולות של קרונוס, ומרחיבה את פורטפוליו המותגים הבינלאומי והמוערך של החברה לאחד משווקי הקנאביס המתקדמים, המקצועיים ומבעלי הסטנדרטים הגבוהים בעולם. השלב הראשון של ההשקה כולל חמישה זני תפרחות פרימיום, שגודלו בגידול...

 PRESS RELEASE

Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing B...

Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord Jones® premium cannabis brand in Israel. The introduction marks a significant milestone in Cronos’ borderless product strategy, expanding the Company’s globally recognized brand portfolio into one of the most advanced and discerning medical cannabis markets in the world. The first phase of the launch br...

 PRESS RELEASE

Cronos to enter the Netherlands with acquisition of Europe’s largest a...

Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M1 plus cash earnout of 0.5x normalized EBITDA in 2026 and 2027 Up-front consideration represents approximately 1.4x CanAdelaar LTM revenue and 2.4x LTM EBITDA2 Will give Cronos #1 market share3 in the largest adult-use cannabis market in Europe Enables borderless product strategy, leveraging investments in genetics, R&D, and product development TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON)...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch